Abstract

In 1948, Kenneth Maxcy(65) wrote in a chapter on epidemiology, “The simplest of all infectious diseases is measles.” That was before the virus had been isolated or any serological test had become available, but the statement is true now, more than 25 yr later, as it was then. This relative simplicity makes measles an ideal model for the study of infectious disease epidemiology. Babbott and Gordon (5) reviewed our knowledge of measles epidemiology as of 1954. Much has been clarified since.

Keywords

Influenza Assimilation Egypt Encephalitis Argentina 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abu Becr, M., A Discourse on the Smallpox and Measles (trans. R. Mead), J. Brindley, London, 1748.Google Scholar
  2. 2.
    Adams, J. M., Clinical pathology of measles encephalitis and sequelae. Neurology 18: 52–56 (1968).PubMedGoogle Scholar
  3. 3.
    Adams, J. M., and Imagawa, D. T., Measles antibodies in multiple sclerosis, Proc. Soc. Exp. Biol. Med. 111: 562–566 (1962).PubMedGoogle Scholar
  4. 4.
    Babbott, F. L., Galbraith, N. S., McDonald, J. C., Shaw, A., and Zuckerman, A. J., Deaths from measles in England and Wales in 1961, Mon. Bull. Minist. Health Public Health Lab. Serv. 22: 167–175 (1963).Google Scholar
  5. 5.
    Babbott, F. L., and Gordon, J. E., Modem measles. Am. f. Med. Sci. 228: 334–361 (1954).Google Scholar
  6. 6.
    Bailey, N. T. J., The Mathematical Theory of Epidemics, Griffin, London, 1957.Google Scholar
  7. 7.
    Bartlett, M. S., Deterministic and stochastic models for recurrent epidemics. Third Berkeley Symp. Math. Stat. Prob. 4: 81–109 (1956).Google Scholar
  8. 8.
    Bartlett, M. S., Measles periodicity and community size, J. R. Stat. Soc. Ser. A 120: 40–70 (1957).Google Scholar
  9. 9.
    Bartlett, M. S., The critical community size for measles in the United States, J. R. Stat. Soc. Ser. A 123: 37–44 (1960).CrossRefGoogle Scholar
  10. 10.
    Bech, V.. Studies on the development of complement fixing antibodies in measles patients, J. Immunol. 83: 267–275 (1959).PubMedGoogle Scholar
  11. 11.
    Bech, V., Measles epidemics in Greenland, Am. J. Dis. Child. 103: 252–253 (1962).PubMedGoogle Scholar
  12. 12.
    Bech, V., The measles epidemic in Greenland, Arch. Gesamte Virusforsch. 16: 53–56 (1965).PubMedCrossRefGoogle Scholar
  13. 13.
    Bellanti, J. A., Sanga, R. L., Klutinis, B., Brandt, B., and Artenstein, M. S., Antibody responses in serum and nasal secretion of children immunized with inactivated and attenuated measles virus vaccines, N. Engl. J. Med. 280: 628–633 (1969).PubMedCrossRefGoogle Scholar
  14. 14.
    Benjamin, B., and Ward, S. M., Leukocyte response to measles. Am. J. Dis. Child. 44: 921–963 (1932).Google Scholar
  15. 15.
    Berg, R. B., and Rosenthal, M. S., Propagation of measles virus in suspensions of human and monkey leukocytes, Proc. Soc. Exp. Biol. Med. 106: 581–585 (1961).Google Scholar
  16. 16.
    Bertrams, J., and Kuwert, E., H-LA antigen segregation analysis in multiple sclerosis. Lancet ii: 43–44 (1974).Google Scholar
  17. 17.
    Bhatt, P. N., Brandt, C. D., Weiss, R. A., Fox, J. P., and Shaffer, M. F., Viral infections of monkeys in their natural habitat in southern India, Am. J. Trop. Med. Hyg. 15: 561–566 (1966).PubMedGoogle Scholar
  18. 18.
    Black, F. L., Growth and stability of measles virus. Virology 7: 184–192 (1959).PubMedCrossRefGoogle Scholar
  19. 19.
    Black, F. L., A nationwide survey of United States military recruits, 1962. III. Measles and mumps antibodies, Am. J. Hyg. 80: 304–307 (1964).PubMedGoogle Scholar
  20. 20.
    Black, F. L., Measles endemicity in insular populations: Critical community size and its evolutionary implication, Theor. Biol. 11: 207–211 (1965).CrossRefGoogle Scholar
  21. 21.
    Black, F. L., Measles, in: Manual of Clinical Microbiology, 2nd ed. ( E. H. Lennette and J. P. Truant, eds.), American Society of Microbiology, Bethesda, Md., 1974.Google Scholar
  22. 22.
    Black, F. L., and Davis, D. E. M., Measles and readiness for reading and learning. II. New Haven Shidy, Am. J. Epidemiol. 88: 337–344 (1968).PubMedGoogle Scholar
  23. 23.
    Black, F. L., Hierholzer, W., Woodall, J. P., and Pinheiro, F., Intensified reactions to measles vaccine in unexposed populations of American Indians, J. Infect. Dis. 124: 306–317 (1971).PubMedCrossRefGoogle Scholar
  24. 24.
    Black, F. L., and Rosen, L., Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure, J. Immunol. 88: 725–731 (1962).PubMedGoogle Scholar
  25. 25.
    Black, F. L., and Sheridan, S. R., Studies on attenuated measles-virus vaccine. IV. Administration of vaccine by several routes, N. Engl. J. Med. 263: 166–170 (1960).CrossRefGoogle Scholar
  26. 26.
    Black, F. L., and Sheridan, S. R., Blood leukocyte response to live measles vaccine. Am. J. Dis. Child. 113: 301–304 (1967).PubMedGoogle Scholar
  27. 27.
    Blake, F. C., and Trask, J. D., Studies on measles. II. Symptomatology and pathology in monkeys experimentally infected, J. Exp. Med. 33: 413–422 (1921).PubMedCrossRefGoogle Scholar
  28. 28.
    Bridges, E. L., Uttermost Part of the Earth, Dutton, New York, 1949.Google Scholar
  29. 29.
    Brown, P., Basright, M., and Gajdusek, D. C., Response to live attenuated measles vaccine in susceptible island populations in Micronesia, Am. J. Epidemiol. 82: 115–122 (1965).PubMedGoogle Scholar
  30. 30.
    Celers, J., Problèmes de santé publique posés par la rougeole dans les pay favorisés. Arch. Gesamte Virusforsch. 16: 5–18 (1965).PubMedCrossRefGoogle Scholar
  31. 31.
    Chalmers, A. K., The Health of Glasgow 1818–1925, Bell and Bain, Glasgow, 1930.Google Scholar
  32. 32.
    Cherry, J. D., Feigin, R. D., Lobes, L. A., Jr., Hinthorn, D. R., Shackleford, P. G., Shirley, R. H., Lins, R. D., and Choi, S. C., Urban measles in the vaccine era: A clinical, epidemiologic and serologic study, J. Pediat. 81: 217–230 (1972).PubMedCrossRefGoogle Scholar
  33. 33.
    Christensen, P. E., Henning, S., Bang, H. O., Andersen, V., Jordal, B., and Jensen, O., An epidemic of measles in southern Greenland, 1951. Measles in virgin soil. II. The epidemic proper. Acta Med. Scand. 144: 430–449 (1952).CrossRefGoogle Scholar
  34. 34.
    Ciongoli, A. K., Platz, P., Dupont, B., Svejgaard, A., Fog, T., and Jerslid, C., Lack of antigen response to myxoviruses in multiple sclerosis. Lancet ii: 1147 (1973).Google Scholar
  35. 35.
    Corney, B. G., The behavior of certain epidemic diseases in natives of Polynesia with especial refer-ence to the Fiji Islands, Trans. Epidemiol. Soc. London (n.s.) 3: 76–95 (1884).Google Scholar
  36. 36.
    Detels, R., Brody, J. A., McNew, J., and Edgar, A. H., Further epidemiological studies of sub-acute sclerosing panencephalitis. Lancet ii: 11–14 (1973).Google Scholar
  37. 37.
    Enders, J. F., and Peebles, T. C., Propagation in tissue cultures of cytophathogenic agents from patients with measles, Proc. Soc. Exp. Biol. Med. 86: 277–286 (1954).PubMedGoogle Scholar
  38. 38.
    Fenner, F., The Impact of Civilization on the Biology of Man (S. V. Boyden, ed.). University of Toronto Press, Toronto, 1970.Google Scholar
  39. 39.
    Field, E. J., Cowshall, S., Narang, H. K., and Bell, T. M., Viruses in multiple sclerosis. Lancet ii: 280–281 (1972).Google Scholar
  40. 40.
    Fox, J. P., Black, F. L., and Kogon, A., Measles and readiness for reading and learning. V. Evaluative comparison of the studies and overall conclusions. Am. J. Epidemiol 88: 168–175 (1969).Google Scholar
  41. 41.
    Fulginiti, V. A., Eller, J. J., Downie, A. W., and Kempe, C. H., Altered reactivity to measles virus: Atypical measles in children previously immunized with inactivated measles virus vaccines, J. Am. Med. Assoc. 202: 1075–1080 (1967).CrossRefGoogle Scholar
  42. 41a.
    Gallagher, M., and Flanagan, T. D., Growth of measles in continuous lymphoid cell lines. Fed. Proc. 34: 948 (1975).Google Scholar
  43. 42.
    Gibbs, F. A., Gibbs, E. L., Carpenter, P. R., and Spies, H. W., Electroencephalographic abnormality in “uncomplicated” childhood diseases, J. Am. Med. Assoc. 171: 1050–1055 (1959).PubMedGoogle Scholar
  44. 43.
    Gordon, J. E., Janssen, A. A. J., and Ascoli, W., Measles in rural Guatemala, J. Pediat. 66: 779–786 (1965).PubMedCrossRefGoogle Scholar
  45. 44.
    Greenberg, M., Pellitteri, O., and Eisenstein, D. T., Measles encephalitis. 1. Prophylactic effect of gamma globulin, J. Pediat. 46: 642–647 (1955).PubMedCrossRefGoogle Scholar
  46. 45.
    Gresser, I., and Katz, S. L., Isolation of measles virus from urine, N. Engl. J. Med. 263: 452–454 (1960).PubMedCrossRefGoogle Scholar
  47. 46.
    Griffiths, D. A., The effect of measles vaccination on the incidence of measles in the community, J. R. Stat. Soc. Ser. A 136: 441–449 (1973).CrossRefGoogle Scholar
  48. 47.
    Gulick, L. H., On the climate, diseases and materia medica of the Sandwich (Hawaiian) Islands, N.Y. J. Med. 14: 169–211 (1855).Google Scholar
  49. 48.
    Hamer, W. H., The Milroy lectures on epidemic disease in England—The evidence of variability and persistency of type. Lancet 1: 733–739 (1906).Google Scholar
  50. 49.
    Harris, R. W., Isacson, P., and Karzon, D. T., Vaccine induced hypersensitivity: Reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine, J. Pediat. 74: 552–563 (1969).PubMedCrossRefGoogle Scholar
  51. 50.
    Hedrick, A. W., Monthly estimates of the child population susceptible to measles 1900–1931, Am. J. Hyg. 17: 613–636 (1933).Google Scholar
  52. 51.
    Helms, S., and Helms, P., Tuberculin sensitivity during measles. Acta Tuberc. Scand. 35: 166–171 (1956).Google Scholar
  53. 52.
    Hirsch, A.. Handbook of Geographical and Historical Pathology, Vol. 1, pp. 154–170, New Sydenham Society, London, 1883.Google Scholar
  54. 53.
    Home, F., Medical Facts and Experiments, A. Millar, London, 1759.Google Scholar
  55. 54.
    Horta-Barbosa, L., Fuccilo, D. A., Hamilton, R., Traub, R., Ley, A., and Sever, J. L., Some characteristics of SSPE measles virus, Proc. Soc. Exp. Biol Med. 134: 17–21 (1970).PubMedGoogle Scholar
  56. 55.
    Dejong, J. G., and Winkler, K. O., Survival of measles virus in air. Nature (London) 201: 1054–1055 (1964).CrossRefGoogle Scholar
  57. 56.
    Katz, S. L., and Enders, J. F., Measles virus, in: Diagnostic Procedures for Viral and Rickettsial Infections, 4th ed. ( E. H. Lennette and N. J. Schmidt, eds.), American Public Health Association, New York, 1969.Google Scholar
  58. 57.
    Katz, S. L., Kempe, C. H., Black, F. L., Lepow, M. L., Krugman, S., Haggerty, R. J., and Enders, J. F., Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccination, N. Engl J. Med. 273: 180–184 (1960).CrossRefGoogle Scholar
  59. 58.
    Koprowski, H., The role of hyperergy in measles encephalitis. Am. J. Dis. Child. 103: 273–278 (1962).PubMedGoogle Scholar
  60. 59.
    Kress, S., Schluederberg, A. E., Hornick, R. B., Morse, L. J., Cole, J. L., Slater, E. A., and McCrumb, F. R., Studies with live attenuated measles-virus vaccine. II. Clinical and immunological response of children in an open community. Am. J. Dis. Child. 101: 701–707 (1961).PubMedGoogle Scholar
  61. 60.
    Krugman, S., Giles, J. P., Jacobs, A. M., and Friedman, H., Studies with a further attenuated live measles-virus vaccine. Pediatrics 66: 471–488 (1965).CrossRefGoogle Scholar
  62. 61.
    Krugman, S., Present status of measles and rubella immunization in the United States: A medical progress report, J. Pediat. 78: 1–16 (1971).PubMedCrossRefGoogle Scholar
  63. 62.
    Landlaekni, Heilbrigdisskyslur (Public Health in Iceland), Rikisprentsmidjan Gutenberg, Reykjavik, 1950, 1957.Google Scholar
  64. 63.
    Lepow, M. L., and Nankervis, G. A., Eight-year serological evaluation of Edmonston live measles vaccine, J. Pediat. 75: 407–411 (1969).PubMedCrossRefGoogle Scholar
  65. 64.
    Lumsden, C. E., in: Multiple Sclerosis: A Reappraisal, 2nd ed., Williams and Wilkins, Baltimore, 1972.Google Scholar
  66. 65.
    Maxcy, K. F., Principles and methods of epidemiology, in: Viral and Rickettsial Infections of Man ( T. M. Rivers, ed.), Lippincott, Philadelphia, 1948.Google Scholar
  67. 66.
    McCrumb, F. R, Kress, S., Saunders, E., Snyder, M. J., and Schluederberg, A. E., Studies with live attenuated measles vaccine. I. Clinical and immunological responses in institutionalized children. Am. J. Dis. Child. 101: 689–700 (1961).Google Scholar
  68. 67.
    McNeill, W. H., Plagues and Peoples: A Natural History of Infectious Diseases, Doubleday, New York (in press).Google Scholar
  69. 68.
    Meyer, H. M., Mass vaccination against measles in Upper Volta, Arch. Gesamte Virusforsch. 16: 243–245 (1965).PubMedCrossRefGoogle Scholar
  70. 69.
    Measles—United States, first 36 weeks, 1973, Morbidity Mortality Weekly Rep. 22:310 (1973).Google Scholar
  71. 70.
    Morley, D., The severe measles of West Africa, Proc. R. Soc. Med. 57: 846–849 (1969).Google Scholar
  72. 71.
    Myers, J. M., Assimilation to the ecological and social systems of a community. Am. Sociol Rev. 15: 367–370 (1950).CrossRefGoogle Scholar
  73. 72.
    Neel, J. v., Centerwall, W. R., Chagnon, N. A., and Casey, H. L., Notes on the effects of measles in virgin-soil population of South American Indians, Am. J. Epidemiol 91: 418–429 (1970).Google Scholar
  74. 73.
    Nutels, N., Medical problems of newly contacted Indian groups, PAHO Sci. Pub. 165: 68–76 (1968).Google Scholar
  75. 74.
    Pampiglione, G., Prodromal phase of measles: Some neurophysiological studies, Br. Med. J. ii: 1296–1300 (1964).Google Scholar
  76. 75.
    Panum, P. L., Observations Made During the Epidemic of Measles on the Faroe Islands in the Year 1846, American Publishing Association, New York, 1940.Google Scholar
  77. 76.
    Papp, K., Experiences prouvant que la voie d’infection de la rougeole est la contamination de la muqueuse conjonctivale. Rev. Immunol 20: 27–36 (1956).Google Scholar
  78. 77.
    Payne, F. E., and Baublis, J. V., Decreased reactivity of SSPE strains of measles virus with antibody, J. Infect. Dis. 127: 505–511 (1973).PubMedCrossRefGoogle Scholar
  79. 78.
    Peart, A. F. W., and Nagler, F. P., Measles in the Canadian Arctic 1952, Can. J. Public Health 45: 146–157 (1954).PubMedGoogle Scholar
  80. 79.
    Ristori, C., Boccardo, H., Borgono, J. M., and Armijo, R., Medical importance of measles in Chile, Am. J. Dis. Child. 103: 236–241 (1962).Google Scholar
  81. 80.
    Salmi, A. A., Norrby, E., and Panelius, M., Identification of different measles virus-specific antibodies in the serum and cerebro-spinal fluid from patients with sub-acute sclerosing panencephalitis and multiple sclerosis. Infect. Immun. 6: 248–254 (1972).PubMedGoogle Scholar
  82. 81.
    Schaffner, W., Schluederberg, A. E., and Byrne, E. B., Clinical epidemiology of sporadic measles in a highly immunized population, N. Engl J. Med. 279: 783–789 (1968).PubMedCrossRefGoogle Scholar
  83. 82.
    Schluederberg, A. E., Immune globulins in human viral infections. Nature (London) 205: 1232–1233 (1965).CrossRefGoogle Scholar
  84. 83.
    Schutz, F., Die Epidemiologie der Masern, Gustav Fisher, Jena, 1925.Google Scholar
  85. 84.
    Scrimshaw, N. S., Solomon, J. B., Bruch, H. A., and Gordon, J. E., Studies of diarrheal disease in Central America. VIII. Measles, diarrhea and nutritional deficiency in Guatemala, Am. J. Trop. Med. 15: 625–631 (1966).Google Scholar
  86. 85.
    Sencer, D. J.. Dull, H. B., and Langmuir, A. D., Epidemiologic basis for eradication of measles in 1967, Public Health Rep. 82: 1253–1256 (1967).Google Scholar
  87. 86.
    Soper, H. E., The interpretation of periodicity in disease prevalence, J. R. Stat. Soc. Ser. A 92: 34–61 (1929).CrossRefGoogle Scholar
  88. 87.
    Suringa, D. W. R., Bank, L. J., and Ackerman, A. B., Role of measles in skin lesions and Koplik spots, N. Engl J. Med. 283: 1139–1142 (1970).PubMedCrossRefGoogle Scholar
  89. 88.
    Sydenham, T., The Works of Thomas Sydenham, Vol. 2, pp. 250–251, Sydenham Society, London, 1922.Google Scholar
  90. 89.
    Tooth, J. S. H., and Lewis, I. C., Measles epidemic in a primitive isolated community, Med. J. Aust. 1: 182–186 (1963).Google Scholar
  91. 90.
    Utermohlen, V., and Zabriskie, J. B., A suppression of cellular immunity in patients with multiple sclerosis, J. Exp. Med. 138: 1591–1596 (1973).PubMedCrossRefGoogle Scholar
  92. 91.
    Valdimarsson, H., Agnarsdottir, G., and Lachmann, P. J., Measles virus receptor on human T lymphocytes. Nature (London) 225: 554–556 (1975).CrossRefGoogle Scholar
  93. 92.
    Viera, J. P. B., Jr., Vacinacao dos indios Surui contra o sarapo. Rev. Assoc. Med. Brazil 16: 183–186 (1968).Google Scholar

Copyright information

© Plenum Publishing Corporation 1976

Authors and Affiliations

  • Francis L. Black
    • 1
  1. 1.Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations